Genes in MS Patients Manhasset NY

Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports. "Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release.

Local Companies

Michele Scantlebury
(212) 996-8000
215 E 95Th St
New York, NY
Abdol Nikkah
(718) 547-2011
161 E Gun Hill Rd
Bronx, NY
Stress Busters Wellness
(516) 883-9355
153 Main St
Port Washington, NY
Lawrence Becker
(516) 294-9696
134 Mineola Blvd Ste 302
Mineola, NY
Toby Handler
(516) 565-3300
230 Hilton Ave
Garden City, NY
N Schwartz
(212) 927-6221
160 Wadsworth Ave # 5
New York, NY
Michael Perez
(212) 544-9513
4499 Manhattan College Parkway
Bronx, NY
Anthony Condreras
(718) 824-1185
1960 Williamsbridge Rd
Bronx, NY
Edward Reilly
(718) 745-7242
220 81st St
Brooklyn, NY
Maxine Ann Stephenson
(516) 565-4110
Doctors Immedicare 199 Hempstead Tpke
West Hempstead, NY
Data Provided by:
  

Provided By:

FRIDAY, Sept. 11 (HealthDay News) -- Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports.

"Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release. "This study asked, among those who have MS, why do some do well with the disease while others do poorly, and what might be the genetic determinants of this difference in outcome."

The study, which was scheduled to be presented Friday at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, identified two genes that appear to lead to repair of damage caused by multiple sclerosis in mice.

Multiple sclerosis affects about 330,000 people in the United States. The disease targets the central nervous system and damages the insulation that covers nerves. People with the disease suffer from a variety of symptoms, including loss of strength, vision, balance and muscle coordination.

"It's possible that the identification of these genes may provide the first important clue as to why some patients with MS do well, while others do not," Bieber said in the news release.

More information

Learn more about the disease from the National Multiple Sclerosis Society.

SOURCE: Mayo clinic, news release, Sept. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Genetic Clues for Skin Cancer Therapies Manhasset NY
Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations. Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma.
- Doctor-Patient Talk for Hypertension Manhasset NY
- Exercise for Chemotherapy Patients Manhasset NY
- Gene Therapy for Parkinson's Manhasset NY
- Side Effect Of Chemotherapy Drugs Manhasset NY
- Depression in Heart Disease Patients Manhasset NY
- Differences Between Hospice and Palliative Care Manhasset NY
- Gene Variants and Alzheimer's Risk Manhasset NY
- Hospice: Getting Back Control of Your Life Manhasset NY
- High Blood Pressure Genes Manhasset NY